{
    "title": "Lonza's full-year core EBITDA up 20.7% on vaccine demand",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10442541/Lonzas-year-core-EBITDA-20-7-vaccine-demand.html",
    "date": "2022-01-26",
    "keywords": [
        "burger",
        "ebitda",
        "year",
        "growth",
        "jan",
        "drug",
        "contract",
        "manufacturer",
        "lonza",
        "demand",
        "interest",
        "tax",
        "depreciation",
        "amortisation",
        "statement",
        "wednesday",
        "line",
        "analyst",
        "consensus",
        "website",
        "company",
        "supplier",
        "vaccine",
        "maker",
        "moderna",
        "sector",
        "pandemic",
        "currency",
        "core",
        "margin",
        "improvement",
        "reporting",
        "riham",
        "alkousaa",
        "kirsti",
        "knolle"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}